BR112019008739A2 - distribuição inteligente de moléculas ingeridas e absorvidas - Google Patents

distribuição inteligente de moléculas ingeridas e absorvidas

Info

Publication number
BR112019008739A2
BR112019008739A2 BR112019008739A BR112019008739A BR112019008739A2 BR 112019008739 A2 BR112019008739 A2 BR 112019008739A2 BR 112019008739 A BR112019008739 A BR 112019008739A BR 112019008739 A BR112019008739 A BR 112019008739A BR 112019008739 A2 BR112019008739 A2 BR 112019008739A2
Authority
BR
Brazil
Prior art keywords
liver
fatty acids
chain fatty
bypassing
agent
Prior art date
Application number
BR112019008739A
Other languages
English (en)
Portuguese (pt)
Inventor
M Petyaev Ivan
orlowski Marek
Original Assignee
Immd Sp Zo O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL419363A external-priority patent/PL419363A1/pl
Priority claimed from GBGB1705491.7A external-priority patent/GB201705491D0/en
Application filed by Immd Sp Zo O filed Critical Immd Sp Zo O
Publication of BR112019008739A2 publication Critical patent/BR112019008739A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/36—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds characterised by the fats used
    • A23G1/38—Cocoa butter substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065—Diphenyl-substituted acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/08—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing cocoa fat if specifically mentioned or containing products of cocoa fat or containing other fats, e.g. fatty acid, fatty alcohol, their esters, lecithin, paraffins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112019008739A 2016-11-04 2017-11-03 distribuição inteligente de moléculas ingeridas e absorvidas BR112019008739A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PL419363A PL419363A1 (pl) 2016-11-04 2016-11-04 Inteligentne dostarczanie przyjmowanych i wchłanianych cząsteczek
GB201618733 2016-11-07
GBGB1705491.7A GB201705491D0 (en) 2017-04-05 2017-04-05 Intelligent delivery of ingested and absorbed molecules
PCT/EP2017/078242 WO2018083271A1 (en) 2016-11-04 2017-11-03 Inteligent delivery of ingested and absorbed molecules

Publications (1)

Publication Number Publication Date
BR112019008739A2 true BR112019008739A2 (pt) 2019-07-09

Family

ID=60382179

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019008739A BR112019008739A2 (pt) 2016-11-04 2017-11-03 distribuição inteligente de moléculas ingeridas e absorvidas

Country Status (8)

Country Link
US (2) US11696920B2 (enExample)
EP (1) EP3534884A1 (enExample)
JP (1) JP2019534329A (enExample)
CN (1) CN110198706A (enExample)
BR (1) BR112019008739A2 (enExample)
CA (1) CA3042592A1 (enExample)
IL (1) IL266385A (enExample)
WO (1) WO2018083271A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12094109B2 (en) * 2018-10-19 2024-09-17 Takeda Pharmaceutical Company Limited Image scoring for intestinal pathology
MX2022001238A (es) * 2019-08-13 2022-07-13 Team Foods Colombia Sa Composicion lipidica que comprende antioxidantes y polifenoles naturales como alternativa no farmacologica para el tratamiento y la prevencion de nafld.
CN115305207B (zh) * 2022-07-01 2024-04-12 厦门大学 一种全合成培养基、制备方法及其用于三孢布拉氏霉菌的培养方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05292885A (ja) 1992-04-22 1993-11-09 Asahi Denka Kogyo Kk チョコレート組成物
DK1997498T3 (da) * 2001-06-18 2012-07-30 Neptune Technologies & Bioressources Inc Krillekstrakter til forebyggelse og/eller behandling af kardiovaskulære sygdomme
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
AU2003275419A1 (en) * 2003-10-03 2005-05-19 Green Meadows Research, Llc A And L Goodbody Lotus and methyl donors
WO2006063219A2 (en) * 2004-12-09 2006-06-15 Pro-Health, Inc. Product and method for oral administration of nutraceuticals
ES2241503B2 (es) * 2005-04-19 2008-07-01 Eduardo Sabio Rey Procedimiento para preparar formulaciones enriquecidas en licopeno libres de disolventes organicos, formulaciones obtenidas, composiciones que comprenden dichas formulaciones y uso de las mismas.
AU2011218634B2 (en) 2005-10-26 2013-06-20 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
JP2010538674A (ja) * 2007-09-19 2010-12-16 オフサルモファーマ・アクチェンゲゼルシャフト 栄養補助剤およびそのような補助剤を含む強化食品
JP5950292B2 (ja) 2008-12-05 2016-07-13 味の素株式会社 栄養組成物
US20100159029A1 (en) 2008-12-23 2010-06-24 Alcon Research, Ltd. Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response
IT1393710B1 (it) * 2009-04-29 2012-05-08 Graal Srl Composizioni orobuccali contenenti una miscela di luteina e zeaxantina.
EP2542096B1 (en) * 2010-03-05 2015-07-15 Ophthalmopharma AG Nutraceutical chocolate or compound chocolate product
US20140205627A1 (en) * 2010-04-30 2014-07-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition and method to improve blood lipid profiles and reduce low density lipoprotein (ldl) per-oxidation in humans using algae based oils and astaxanthin
CN101816330B (zh) * 2010-05-31 2012-04-18 澳优乳业（中国）有限公司 一种含β-胡萝卜素的婴幼儿奶粉及其制备方法
GB201101669D0 (en) 2011-01-31 2011-03-16 Ip Science Ltd Carotenoid particles and uses thereof
US20120252888A1 (en) 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
GB201120772D0 (en) 2011-12-02 2012-01-11 Ip Science Ltd Cocoa-based food products
US20140170247A1 (en) * 2012-09-14 2014-06-19 Guardion Health Sciences, Llc Emulsion of Carotenoids and Ocular Antioxidants
FR2996136B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association d'au moins un acide gras polyinsature et d'au moins un carotenoide pour ameliorer la qualite des ongles.
US9629820B2 (en) * 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
WO2015073515A1 (en) 2013-11-12 2015-05-21 Abbott Laboratories Uses of nutritional compositions including natural vitamin e, and polyunsaturated fatty acid

Also Published As

Publication number Publication date
EP3534884A1 (en) 2019-09-11
US20230310470A1 (en) 2023-10-05
US20200261482A1 (en) 2020-08-20
IL266385A (en) 2019-06-30
CN110198706A (zh) 2019-09-03
CA3042592A1 (en) 2018-05-11
JP2019534329A (ja) 2019-11-28
US11696920B2 (en) 2023-07-11
WO2018083271A1 (en) 2018-05-11

Similar Documents

Publication Publication Date Title
CL2019003105A1 (es) Lípidos extraídos de plantas que comprenden ácidos grasos poliinsaturados de cadena larga. (divisional solicitud 201601560)
MX2018005829A (es) Composiciones para tratar el cabello.
CL2019001682A1 (es) Enriquecimiento enzimático de ácidos grasos n-3 en forma de glicéridos.
MX386161B (es) Composición alimenticia para mascotas que comprende ácidos grasos poliinsaturados.
IL263561B (en) Esters of beta-hydroxybutyrate or butanediol and medium-length fatty acids, preparations containing them and their uses
BR112019008739A2 (pt) distribuição inteligente de moléculas ingeridas e absorvidas
BR112017019505A2 (pt) amortecedor dinâmico, isolador de vibração e método para fabricação de elastômero viscoso magnético
BR112017013691A2 (pt) composição compreendendo um polímero em multiestágio, seu método de preparação e seu uso
EP4389910A3 (en) Isothermal amplification components and processes
GEP201606568B (en) Compositions for the treatment of neurologic disorders
BR112018000214A2 (pt) composições nutricionais e métodos para promoção de desenvolvimento cognitivo
BR112016028692A2 (pt) artigos que fornecem fragrâncias de longa duração
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
BR112016028697A2 (pt) artigos que fornecem fragrâncias de longa duração
MX2017017119A (es) Formulacion de alta concentracion.
AR105190A1 (es) Composiciones nutricionales y métodos para promover el desarrollo cognitivo
BR112017013445A2 (pt) processo para aumentar a estabilidade de uma composição que compreende ácidos graxos ômega 6 poli-insaturados
EP3749297A4 (en) MULTIPLE UNSATURATED FATTY ACID MONOGLYCERIDES, COMPOSITIONS, PROCESSES AND USES THEREOF
CL2018002548A1 (es) Regulación del metabolismo de ornitina para aumentar el contenido de glicoformas ricas en manosa de proteínas recombinantes.(divisional solicitud 201601786)
BR112017015709A8 (pt) Método para preparar uma farinha de microalgas trituradas ricas em lipídio
BR112017004952A2 (pt) unidade de processamento enzimático e méto¬do de processamento enzimático
BR112019003915A2 (pt) composição para tratamento dos cabelos, método de tratamento de cabelo danificado quimicamente e usos de uma composição
BR112016028561A8 (pt) composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas
BR112018074329A2 (pt) composição, formulação seca ou líquida, e, uso de uma composição.
ZA202107552B (en) Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements